Related Experiment Video
Updated: Jul 7, 2026
08:53
Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Alendronate decreases TRACP 5b activity in osteoarthritic bone
Alexander T Mehlhorn1, H Rechl, R Gradinger
1Department of Orthopaedic and Trauma Surgery, Albert-Ludwigs-Universität Freiburg, Hugstetterstr, 55 79106 Freiburg, Germany. mehlhorn@ch11.ukl.uni-freiburg.de
European Journal of Medical Research
|January 30, 2008
Summary
Alendronate treatment reduced tartrate-resistant acid phosphatase 5B (TRACP 5b) activity in osteoarthritic bone, particularly in well-supplied intertrochanteric areas. This indicates bisphosphonates are more effective in these regions.
Area of Science:
- Biochemistry
- Orthopedics
- Pharmacology
Background:
- Osteoarthritis (OA) is a degenerative joint disease characterized by bone remodeling.
- Tartrate-resistant acid phosphatase 5B (TRACP 5b) is a key marker of osteoclast activity, crucial in bone resorption.
- Bisphosphonates, like Alendronate, are commonly used to treat bone disorders by inhibiting osteoclast function.
Purpose of the Study:
- To quantify the activity of TRACP 5b in osteoarthritic bone specimens from patients treated with Alendronate.
- To investigate the effect of Alendronate on TRACP 5b levels in different regions of the femoral head.
- To determine the efficacy of bisphosphonates in specific bone areas affected by osteoarthritis.
Main Methods:
- A randomized controlled study involving 12 patients undergoing total hip replacement.
- Patients were divided into a bisphosphonate (Alendronate) group and a control group.
- Femoral head samples (anterior A1 and intertrochanteric A2) were analyzed using immunoassay for TRACP 5b activity and histological staining for TRACP-positive cells.
Main Results:
- Alendronate treatment significantly decreased TRACP 5b enzyme activity in both anterior femoral head (A1) and intertrochanteric (A2) areas compared to controls.
- TRACP 5b activity was significantly higher in A1 compared to A2 in the bisphosphonate group, but not in the control group.
- Histological examination confirmed fewer TRACP-positive cells in bisphosphonate-treated bone sections, corroborating the enzyme activity findings.
Conclusions:
- Bisphosphonates, specifically Alendronate, effectively reduce TRACP 5b activity in osteoarthritic bone.
- The reduction in TRACP 5b activity by bisphosphonates is more pronounced in the intertrochanteric area (A2) than in the anterior femoral head (A1).
- These findings suggest that bisphosphonates may be more effective in well-vascularized bone regions, highlighting potential differences in therapeutic response within osteoarthritic bone tissue.
Related Concept Videos
01:31Osteoclasts in Bone Remodeling
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:29Bone Disorders
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:21Drug Distribution: Tissue Binding
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:25Role of Vitamins in Maintaining Bone Health
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...